• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[使用长效注射用纳曲酮对阿片类药物成瘾患者实施治疗方案的中期结果分析]

[An interim analysis of the results of treatment program implementation with the use of injectable extended-release naltrexone for opioid addicted patients].

作者信息

Agibalova T V, Nedobylskiy O V, Poplevchenkov K N, Sirotko I I, Shcherban A V, Tsarev S A

机构信息

Moscow Scientific and Practical Center of Narcology of the Department of Health of Moscow, Moscow, Russia.

The Research Institute of Narcology - a branch of Serbsky Federal Medical Research Center for Psychiatry and Narcology, Moscow, Russia.

出版信息

Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(6):32-34. doi: 10.17116/jnevro20171176132-34.

DOI:10.17116/jnevro20171176132-34
PMID:28745668
Abstract

AIM

To analyze outcomes of treatment in the 'Point of soberness' program for opioid addicted patients (2015-2016 гг.).

MATERIAL AND METHODS

The results of treatment of 83 opioid addicted patients were analyzed. Seventy-four (89.16%) patients received treatment course of injections of extended-release naltrexone (from 4 to 6 injections), maintaining their participation in the outpatient medical rehabilitation program. Thirty-six (43.37%) patients completed a full course of injections of extended-release naltrexone.

RESULTS AND CONCLUSION

The high efficacy of complex treatment with naltrexone injections was demonstrated. 89% of patients achieved remission during the course of treatment.

摘要

目的

分析阿片类药物成瘾患者“清醒点”项目(2015 - 2016年)的治疗结果。

材料与方法

分析了83例阿片类药物成瘾患者的治疗结果。74例(89.16%)患者接受了缓释纳曲酮注射治疗疗程(4至6次注射),并持续参与门诊医疗康复项目。36例(43.37%)患者完成了缓释纳曲酮的全程注射。

结果与结论

证明了纳曲酮注射综合治疗的高效性。89%的患者在治疗过程中实现了缓解。

相似文献

1
[An interim analysis of the results of treatment program implementation with the use of injectable extended-release naltrexone for opioid addicted patients].[使用长效注射用纳曲酮对阿片类药物成瘾患者实施治疗方案的中期结果分析]
Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(6):32-34. doi: 10.17116/jnevro20171176132-34.
2
[The efficiency of the medical rehabilitation program with the use of injectable naltrexone for alcohol addicted patients who are at risk of parental rights deprivation].[使用注射用纳曲酮对有被剥夺亲权风险的酒精成瘾患者进行医学康复计划的效果]
Zh Nevrol Psikhiatr Im S S Korsakova. 2018;118(2):40-44. doi: 10.17116/jnevro20181182140-44.
3
A multisite pilot study of extended-release injectable naltrexone treatment for previously opioid-dependent parolees and probationers.一项多中心试点研究:使用缓释型纳曲酮注射剂治疗曾有阿片类药物依赖史的假释犯和缓刑犯。
Subst Abus. 2012;33(1):48-59. doi: 10.1080/08897077.2011.609438.
4
Sublingual Buprenorphine-Naloxone Compared With Injection Naltrexone for Opioid Use Disorder: Potential Utility of Patient Characteristics in Guiding Choice of Treatment.舌下丁丙诺啡-纳洛酮与注射用纳曲酮治疗阿片类药物使用障碍的比较:患者特征在指导治疗选择中的潜在作用。
Am J Psychiatry. 2021 Jul;178(7):660-671. doi: 10.1176/appi.ajp.2020.20060816. Epub 2021 Jun 25.
5
Retention in naltrexone implant treatment for opioid dependence.纳曲酮植入物治疗阿片类药物依赖的保持率。
Drug Alcohol Depend. 2010 Sep 1;111(1-2):166-9. doi: 10.1016/j.drugalcdep.2010.03.021. Epub 2010 May 31.
6
Extended-release injectable naltrexone for opioid use disorder: a systematic review.长效注射用纳曲酮治疗阿片类药物使用障碍:系统评价。
Addiction. 2018 Jul;113(7):1188-1209. doi: 10.1111/add.14180. Epub 2018 Mar 24.
7
Treatment of opioid dependence in adolescents and young adults with extended release naltrexone: preliminary case-series and feasibility.用缓释纳曲酮治疗青少年和年轻成人阿片类药物依赖:初步病例系列和可行性。
Addiction. 2010 Sep;105(9):1669-76. doi: 10.1111/j.1360-0443.2010.03015.x. Epub 2010 Jul 9.
8
Outpatient transition to extended-release injectable naltrexone for patients with opioid use disorder: A phase 3 randomized trial.门诊患者向阿片类药物使用障碍患者过渡使用长效纳曲酮注射剂:一项 3 期随机试验。
Drug Alcohol Depend. 2018 Jun 1;187:171-178. doi: 10.1016/j.drugalcdep.2018.02.023. Epub 2018 Apr 10.
9
A week-long outpatient induction onto XR-naltrexone in patients with opioid use disorder.为期一周的门诊 XR-纳曲酮诱导治疗,用于治疗阿片类药物使用障碍患者。
Am J Drug Alcohol Abuse. 2020 May 3;46(3):289-296. doi: 10.1080/00952990.2019.1700265. Epub 2019 Dec 20.
10
Advances in opioid antagonist treatment for opioid addiction.阿片类拮抗剂治疗阿片类成瘾的进展。
Psychiatr Clin North Am. 2012 Jun;35(2):297-308. doi: 10.1016/j.psc.2012.03.002. Epub 2012 Apr 10.